Phenoxymethylpenicillin, also known as penicillin V and penicillin VK, is an antibiotic useful for the treatment of a number of bacterial infections. Specifically it is used for the treatment of strep throat, otitis media, and cellulitis. It is also used + some more technical info. Phenoxymethylpenicillin is an orally active beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins and interfering with peptidoglycan cross-linking, producing a bactericidal effect against many gram positive organisms, especially streptococci and some anaerobes. The molecule is more acid stable than benzylpenicillin, permitting reliable oral dosing; oral bioavailability is moderate and variable, commonly reported in the range of about 50 to 65 percent. After absorption it is distributed to extracellular fluids, has limited penetration into cerebrospinal fluid unless meninges are inflamed, and is largely eliminated by renal excretion with a plasma half-life on the order of roughly 0.5 to 1 hour in subjects with normal renal function. Common analytical and quality control considerations include assay by HPLC with UV detection, monitoring of related substances, and confirmation of salt form and potency.
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin / Etacrynic Acid
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin Potassium / Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Parent: Phenoxymethylpenicillin
Typical quality specifications for phenoxymethylpenicillin include assay purity expectations and limits for related substances measured by validated chromatographic methods. Assay acceptance is commonly specified as not less than 95.0 percent and not more than 105.0 percent of the labeled amount for finished dosage forms, depending on the monograph applied. Related compound controls commonly include limits such as individual unspecified impurities not exceeding 0.5 percent by area and total impurities not exceeding 2.0 percent by area when measured by HPLC, with specific known degradants and related substances monitored routinely: penicilloic acid, penilloic acid, penillic acid, and traces of 6-aminopenicillanic acid. Specific impurity limits used in manufacturing and release testing can vary by pharmacopeial monograph and regulatory filing, but common practical thresholds are penicilloic acid up to about 0.5 percent, penilloic and penillic species each up to about 0.5 percent, and a combined related substances limit near 2.0 percent. Stability testing also monitors for moisture related hydrolysis and for increases in penicilloic acid over time; analytical control uses validated HPLC gradient methods, system suitability checks, and appropriate reference standards.
Phenoxymethylpenicillin is used to treat susceptible bacterial infections of the upper respiratory tract and skin, most frequently streptococcal pharyngitis, otitis media, and uncomplicated cellulitis caused by penicillin-sensitive organisms; it is chosen for oral therapy when a narrow spectrum penicillin is appropriate.
Phenoxymethylpenicillin can alter normal microbial flora and predispose to overgrowth of Candida species, so oral or vaginal thrush is a possible side effect; risk increases with prolonged or repeated courses, concurrent corticosteroid use, or immunosuppression, and patients with new oral white patches or genital symptoms should seek medical advice.
No, phenoxymethylpenicillin and amoxicillin are both beta-lactam penicillins but they differ in spectrum and pharmacokinetics; amoxicillin has broader activity against some gram negative organisms and often achieves higher oral absorption and longer dosing intervals, while phenoxymethylpenicillin is narrower spectrum and is commonly used when streptococcal coverage is the main goal.
Recommended dosing varies by indication, age, weight, and regional guidelines; typical adult regimens are 250 to 500 mg administered every 6 to 8 hours, and pediatric dosing is usually weight based at about 25 to 50 mg per kg per day divided into multiple doses; always follow the prescribing physician or local product label for exact dose and duration.
